---
title: "Spanish grammaticality judgment task reveals morphosyntactic and transitivity deficits in PPA and"
id: "medrxiv-0-a-spanish-grammaticality-judgment-task-for-neurodegenerative-diseases"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-0-a-spanish-grammaticality-judgment-task-for-neurodegenerative-diseases"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.25.26360651v1?rss=1"
published_at: "2026-08-28T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Spanish grammaticality judgment task reveals morphosyntactic and transitivity deficits in PPA and
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-0-a-spanish-grammaticality-judgment-task-for-neurodegenerative-diseases
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.25.26360651v1?rss=1)
- **Published At:** 2026-08-28T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study developed a computer-based **Spanish grammaticality judgment** task assessing nominal and verbal **inflectional** morphology, **transitivity**, and **word order** comprehension for use in neurodegenerative populations. - Participants included Spanish-speaking patients with the three variants of primary progressive aphasia (non-fluent/agrammatic, logopenic, semantic) and typical **Alzheimer’s Disease**; exact sample sizes were not reported in the source abstract. - Psychometric evaluation showed the task had **good sensitivity**, internal consistency, and a moderate correlation of task accuracy with broader language and neuropsychological measures. - All four clinical groups maintained the ability to accept grammatical sentences but had selective difficulty rejecting ungrammatical or unacceptable ones, indicating a bias or impaired detection of violations. - Both AD and the three PPA variants showed impaired comprehension of **inflectional** morphology and **transitivity** information, while sensitivity to **word order** was relatively spared. - Exploratory analyses linked performance differences to cognitive domains: **short-term memory**, **working memory**, and **verbal semantics** were differentially associated with sentence evaluation performance across and within groups. - Voxel-based morphometry (VBM) analyses identified the **left posterior temporal cortex** as the primary neuroanatomical correlate of grammaticality judgment performance. - The findings extend prior English-language work to Spanish, supporting that morphosyntactic and transitivity deficits are cross-linguistically robust features of neurodegenerative language decline and highlighting the need for language-sensitive assessment tools in underrepresented languages. - Ethical approval was obtained from the Ethics Committee of the Hospital Sant Pau. Data from the study are available on reasonable request to the authors. - Competing interests disclosed include several authors reporting advisory roles, honoraria, and patents; other authors declared no competing interests.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=2jiSuz6yvIdlzW2P2cZJFVWDbItlzmMoDboaMwvqnFg-1787969415.0307724-1.2.1.1-DOGcasY11jiVme5Lx0LZNJ4Ri4oZkAN9FCkE5Yw2okjF5.7ga0C_FqrzyCLXfcWY) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.25.26360651v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # A Spanish grammaticality judgment task for neurodegenerative diseases: inflectional, transitivity, and word order comprehension in PPA and Alzheimer's Disease [ View ORCID Profile](http://orcid.org/0000-0001-9514-7862)Simona Mancini, [ View ORCID Profile](http://orcid.org/0000-0002-0200-4414)Nicoletta Biondo, [ View ORCID Profile](http://orcid.org/0000-0003-4373-1316)Marco Calabria, [ View ORCID Profile](http://orcid.org/0000-0003-2701-5045)Clara Martin, Estefania Garcia Hernandez, Julia Filella Merce, Judit Selma, Jesus Garcia Castro, Sara Rubio, Isabel Sala, Maria Belen Sanchez Saudinos, [ View ORCID Profile](http://orcid.org/0000-0001-5287-3012)Stephanie Grasso, [ View ORCID Profile](http://orcid.org/0000-0002-5418-2052)Ignacio Illan-Gala, Alexandre Bejanin, [ View ORCID Profile](http://orcid.org/0000-0002-2568-5478)Alberto Lleo, Juan Fortea, [ View ORCID Profile](http://orcid.org/0000-0003-1567-617X)Miguel Angel Santos Santos doi: https://doi.org/10.64898/2026.08.25.26360651 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Simona Mancini 1 Basque Center on Cognition Brain and Language, Donostia-San Sebastian, Spain; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Simona%2BMancini%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Mancini%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASimona%2BMancini%2B) * [ORCID record for Simona Mancini](http://orcid.org/0000-0001-9514-7862 "Open in new tab") * For correspondence: s.mancini@bcbl.eu Nicoletta Biondo 1 Basque Center on Cognition Brain and Language, Donostia-San Sebastian, Spain; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Nicoletta%2BBiondo%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Biondo%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANicoletta%2BBiondo%2B) * [ORCID record for Nicoletta Biondo](http://orcid.org/0000-0002-0200-4414 "Open in new tab") Marco Calabria 2 Faculty of Health Sciences, Universitat Oberta de Catalunya, Barcelona, Spain; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Marco%2BCalabria%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Calabria%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMarco%2BCalabria%2B) * [ORCID record for Marco Calabria](http://orcid.org/0000-0003-4373-1316 "Open in new tab") Clara Martin 3 Basque Center on Cognition Brain and Language, Donostia-San Sebastin, Spain; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Clara%2BMartin%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Martin%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AClara%2BMartin%2B) * [ORCID record for Clara Martin](http://orcid.org/0000-0003-2701-5045 "Open in new tab") Estefania Garcia Hernandez 4 Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Pau, Barcelona, Spain; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Estefania%2BGarcia%2BHernandez%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Garcia%20Hernandez%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEstefania%2BGarcia%2BHernandez%2B) Julia Filella Merce 4 Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Pau, Barcelona, Spain; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Julia%2BFilella%2BMerce%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Filella%20Merce%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJulia%2BFilella%2BMerce%2B) Judit Selma 5 Sant Pau Memory Unit, Department of Neurology, Hospital Santa Creu i Pau, Barcelona, Spain; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Judit%2BSelma%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Selma%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJudit%2BSelma%2B) Jesus Garcia Castro 6 Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jesus%2BGarcia%2BCastro%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Garcia%20Castro%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJesus%2BGarcia%2BCastro%2B) Sara Rubio 6 Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sara%2BRubio%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Rubio%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASara%2BRubio%2B) Isabel Sala 6 Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Isabel%2BSala%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Sala%20I&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AIsabel%2BSala%2B) Maria Belen Sanchez Saudinos 6 Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Maria%2BBelen%2BSanchez%2BSaudinos%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Sanchez%20Saudinos%20MB&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMaria%2BBelen%2BSanchez%2BSaudinos%2B) Stephanie Grasso 7 UT Austin; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Stephanie%2BGrasso%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Grasso%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AStephanie%2BGrasso%2B) * [ORCID record for Stephanie Grasso](http://orcid.org/0000-0001-5287-3012 "Open in new tab") Ignacio Illan-Gala 8 Hospital de la Santa Creu i Sant Pau; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ignacio%2BIllan-Gala%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Illan-Gala%20I&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AIgnacio%2BIllan-Gala%2B) * [ORCID record for Ignacio Illan-Gala](http://orcid.org/0000-0002-5418-2052 "Open in new tab") Alexandre Bejanin 6 Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Alexandre%2BBejanin%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Bejanin%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAlexandre%2BBejanin%2B) Alberto Lleo 9 Hospital Sant Pau; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Alberto%2BLleo%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Lleo%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAlberto%2BLleo%2B) * [ORCID record for Alberto Lleo](http://orcid.org/0000-0002-2568-5478 "Open in new tab") Juan Fortea 10 Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Juan%2BFortea%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Fortea%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJuan%2BFortea%2B) Miguel Angel Santos Santos 11 INSTITUT DE RECERCA HOSPITAL DE LA SANTA CREU I SANT PAU * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Miguel%2BAngel%2BSantos%2BSantos%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Santos%20Santos%20MA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMiguel%2BAngel%2BSantos%2BSantos%2B) * [ORCID record for Miguel Angel Santos Santos](http://orcid.org/0000-0003-1567-617X "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.25.26360651v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1288135/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.25.26360651v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1288135/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.25.26360651v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1288135/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.08.25.26360651v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1288135/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.25.26360651v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1288135/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.25.26360651v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1288135/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Impairment in the comprehension of morphosyntactic and transitivity information does not feature in current diagnostic guidelines for primary progressive aphasia (PPA) or Alzheimer's Disease (AD), despite research reporting delayed sensitivity or insensitivity of these clinical populations to these linguistic domains. Moreover, studies rarely compare all three PPA variants and AD within a single design, and the literature is weighted toward English, whose reduced morphology may not capture the full range of comprehension difficulties these populations experience. We developed a computer-based acceptability judgment task covering comprehension of the nominal and verbal inflection paradigm in Spanish, transitivity and word order. We recruited Spanish-speaking patients diagnosed with non-fluent/agrammatic, logopenic and semantic variants of PPA and typical AD. Psychometric evaluation confirmed good sensitivity, internal consistency and moderate correlation of task accuracy with language and neuropsychological measures. The four clinical groups retained the ability to endorse grammatical sentences but showed selective difficulty rejecting unacceptable ones. AD and the three PPA variants showed impaired comprehension of inflectional and transitivity information, whereas sensitivity to word order was comparatively preserved. Exploratory analyses revealed that short-term memory, working memory, and verbal semantics were differentially associated with sentence evaluation performance within and across groups. VBM analyses identified the left posterior temporal cortex as the main neuroanatomical correlate of grammaticality judgment performance. These findings extend prior English-language research to Spanish, demonstrating that morphosyntactic and transitivity deficits are a robust and cross-linguistically consistent feature of neurodegenerative language decline, and highlighting the importance of developing language-sensitive assessment tools for underrepresented linguistic populations. ### Competing Interest Statement Juan Fortea reported serving on the advisory boards, adjudication committees, or speaker honoraria from AC Immune, Adamed, Alzheon, Biogen, Eisai, Esteve, Fujirebio, Ionis, Laboratorios Carnot, Life Molecular Imaging, Lilly, Novo Nordisk, Perha, Roche, Zambon. JF reports holding a patent for markers of synaptopathy in neurodegenerative disease (licensed to ADx, WO2019175379). Alberto Lleo has served as a consultant or on advisory boards for Almirall, Beckman Coulter, Fujirebio-Europe, NovoNordisk, Roche, Biogen, Grifols, Novartis, Eisai, Lilly, and Nutricia, outside the submitted work. AL reports holding a patent for markers of synaptopathy in neurodegenerative disease (licensed to ADx, WO2019175379). Ignacio Illan-Gala participated in advisory boards from UCB and Nutricia, and received speaker honoraria from Almirall, Esteve Pharmaceuticals S.A, Kern Pharma, Krka Farmaceutica S.L., Lilly, Nutricia, and Zambon S.A.U. No other competing interests were reported. The remaining authors declare no competing interests. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Ethics Committee of the Hospital Sant Pau gave ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data produced in the present study are available upon reasonable request to the authors ## Funder Information Declared Ministerio de Ciencia, Innovación y Universidades, https://ror.org/05r0vyz12, PID2024-159519OB-I00, CEX2020-001010/AEI/10.13039/501100011033 Instituto de Salud Carlos III, https://ror.org/00ca2c886, JR18-00018, PI19/00882, PI22/00307, PI22/00611, PI24/00598, PI24/00968, PI24/01087, INT19/00016, INT23/00048, AC19/00103, DTS22/00111, PI25/00422 Alzheimer's Association, https://ror.org/0375f4d26, AACSF-22-972945, 24AARG-D-1246996 National Institutes of Health, https://ror.org/01cwqze88, R01AG080470, 1R01AG056850-01A1, R21AG056974, R01AG080470, R01AG061566 Generalitat de Catalunya, https://ror.org/01bg62x04, 2017-SGR-547, SLT006/17/125, SLT006/17/119, SLT002/16/408, SLT042/25/000034, 2021 SGR 00979 Marató TV3, 20141210, 044412, 20142610 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.25.26360651v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.26.26361391v1 "Loss to Follow-Up Among Patients with Kaposi Sarcoma at the Ocean Road Cancer Institute, Tanzania: A Fine–Gray Competing-Risks Analysis of Death as a Competing Event")[Next ](https://www.medrxiv.org/content/10.64898/2026.08.25.26361379v1 "Project ECHO for patients with chronic intestinal failure: Empowering people living with rare disease using a virtual telelearning model") Posted August 28, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2
## Related Clinical Research

- [Characteristics, Comorbidities, Medications, and Resource Use in Patients Newly Diagnosed with Alz](https://medichelpline.com/clinical-feed/bmj-open-5-characterising-patients-with-alzheimers-disease-in-england-a-cohort-study-using.md)
- [Federal autism advisory committee highlights vaccines and shifts research priorities away from gen](https://medichelpline.com/clinical-feed/stat-news-2-at-a-federal-autism-advisory-committee-meeting-members-double-down-on-long.md)
- [MTHFR 677C>T variant drives prodromal cerebrovascular and synaptic signatures in a mouse model of](https://medichelpline.com/clinical-feed/biorxiv-0-mthfr-677c-t-produces-distinct-prodromal-disease-signatures-in-a-mouse-model-of.md)
- [Genetic links to EEG features in mild cognitive impairment reveal pathways relevant to Alzheimer’s](https://medichelpline.com/clinical-feed/medrxiv-1-genetic-associations-with-eeg-signatures-in-mild-cognitive-impairment-insights.md)
- [Integrating speech (acoustic & linguistic) with cognitive testing to detect early cognitive impair](https://medichelpline.com/clinical-feed/medrxiv-14-integrating-cognitive-linguistic-and-acoustic-features-to-identify-individuals.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.